J. Michael Pearson has returned as the chief executive of Valeant Pharmaceuticals International after two months of medical leave, setting him up for the challenge of restoring investor confidence in the embattled company.
Valeant announced Sunday evening that Mr. Pearson had returned, effective immediately. Howard B. Schiller, who had been the interim chief executive in Mr. Pearson’s absence, will step down as a company executive but remain a member of the board.
Also read: Halliburton President to Become CEO
18:50 Goldman's Donovan still open to Treasury role, despite declining #2 spot9
22:20 Rawle Alkins will return for sophomore season at Arizona12
21:32 Betsy DeVos hits hard reset on student loan servicing contracts19
09:45 This Startup Is Telling Everyday Investors It Will Be The Next Uber31